These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
712 related articles for article (PubMed ID: 26620035)
61. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity. Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682 [TBL] [Abstract][Full Text] [Related]
62. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. McPherson S; Hardy T; Henderson E; Burt AD; Day CP; Anstee QM J Hepatol; 2015 May; 62(5):1148-55. PubMed ID: 25477264 [TBL] [Abstract][Full Text] [Related]
63. [Non-alcoholic fatty liver disease in children and adolescents]. Björklund J; Laursen TL; Kazankov K; Thomsen KL; Hamilton-Dutoit S; Stenbøg E; Grønbæk H Ugeskr Laeger; 2017 Jul; 179(27):. PubMed ID: 28689548 [TBL] [Abstract][Full Text] [Related]
64. Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis. Leoni S; Tovoli F; Napoli L; Serio I; Ferri S; Bolondi L World J Gastroenterol; 2018 Aug; 24(30):3361-3373. PubMed ID: 30122876 [TBL] [Abstract][Full Text] [Related]
65. Causes of secondary non-alcoholic fatty liver disease in non-obese children below 10 years. Mogahed EA; Sayed AA; Khalifa SE; El-Hennawy A; El-Raziky MS Eur J Pediatr; 2020 May; 179(5):719-726. PubMed ID: 31897838 [TBL] [Abstract][Full Text] [Related]
67. Systems biology approaches for studying the pathogenesis of non-alcoholic fatty liver disease. Fisher CP; Kierzek AM; Plant NJ; Moore JB World J Gastroenterol; 2014 Nov; 20(41):15070-8. PubMed ID: 25386055 [TBL] [Abstract][Full Text] [Related]
68. Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease. Tallino S; Duffy M; Ralle M; Cortés MP; Latorre M; Burkhead JL J Nutr Biochem; 2015 Oct; 26(10):996-1006. PubMed ID: 26033743 [TBL] [Abstract][Full Text] [Related]
78. Non-alcoholic fatty liver disease: a diabetologist's perspective. Pappachan JM; Antonio FA; Edavalath M; Mukherjee A Endocrine; 2014 Apr; 45(3):344-53. PubMed ID: 24287794 [TBL] [Abstract][Full Text] [Related]
79. Non-alcoholic fatty liver disease: A growing public health problem in Turkey. Kaya E; Yılmaz Y Turk J Gastroenterol; 2019 Oct; 30(10):865-871. PubMed ID: 31258135 [TBL] [Abstract][Full Text] [Related]
80. Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016. Kaswala DH; Lai M; Afdhal NH Dig Dis Sci; 2016 May; 61(5):1356-64. PubMed ID: 27017224 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]